Publications by authors named "Tim R de Back"

Claim this Profile
P
Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20-year nationwide cohort study.
Jasmijn D G Linssen, Pascale J M Schafrat, Tim R de Back, Felice N van Erning, Monique E van Leerdam

Int J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues.
Tim R de Back, Tan Wu, Pascale Jm Schafrat, Sanne Ten Hoorn, Miaomiao Tan

Life Sci Alliance· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic subtyping of gastrointestinal malignancies.
Tim R de Back, Sander R van Hooff, Dirkje W Sommeijer, Louis Vermeulen

Trends Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues.
Tim R de Back, Tan Wu, Pascale Jm Schafrat, Sanne Ten Hoorn, Miaomiao Tan

Life Sci Alliance· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, clinical management and prognosis of patients with small intestinal adenocarcinomas from 1999 through 2019: A nationwide Dutch cohort study.
Tim R de Back, Jasmijn D G Linssen, Felice N van Erning, Caitlin S E Verbakel, Pascale J M Schafrat

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer.
Sanne Ten Hoorn, Linda Mol, Dirkje W Sommeijer, Lisanne Nijman, Tom van den Bosch, Tim R de Back

Clin Colorectal Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.
Ronja S Adam, Dennis Poel, Leandro Ferreira Moreno, Joey M A Spronck, Tim R de Back

Mol Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Sanne Ten Hoorn, Tim R de Back, Dirkje W Sommeijer, Louis Vermeulen

J Natl Cancer Inst· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone.
Sanne Ten Hoorn, Dirkje W Sommeijer, Faye Elliott, David Fisher, Tim R de Back

Br J Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.
Aafke E Gaartman, Ajab K Sayedi, Jorn J Gerritsma, Tim R de Back, Charlotte F van Tuijn

Br J Haematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.
Tim R De Back, Arnon P Kater, Sanne H Tonino

Expert Rev Hematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Health and Related Health Care Use of Moluccan-Dutch Immigrants.
Tim R de Back, Adee J Bodewes, Lizzy M Brewster, Anton E Kunst

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis